Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Product: Eryhexal. Active Ingredient(s): Erythromycin ethylsuccinate 4.935 g. Dosage Form: Powder for oral suspension. NZ Sponsor: Hexal New Zealand Pty Limited. Manufacturer(s): Allphamed Pharmaceuticals Company Pty Limited, Gottingen, Germany. Product: Eryhexal. Active Ingredient(s): Erythromycin ethylsuccinate 11.838 g. Dosage Form: Powder for oral suspension. NZ Sponsor: Hexal New Zealand Pty Limited. Manufacturer(s): Allphamed Pharmaceuticals Company Pty Limited, Gottingen, Germany. Product: NovoNorm. Active Ingredient(s): Repaglinide 0.5 mg. Dosage Form: Tablet. NZ Sponsor: Novo Nordisk Pharmaceuticals Limited. Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany. Product: NovoNorm. Active Ingredient(s): Repaglinide 1 mg. Dosage Form: Tablet. NZ Sponsor: Novo Nordisk Pharmaceuticals Limited. Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany. Product: NovoNorm. Active Ingredient(s): Repaglinide 2 mg. Dosage Form: Tablet. NZ Sponsor: Novo Nordisk Pharmaceuticals Limited. Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany. Dated this 29th day of July 1999. G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).